Patents by Inventor Shen Shen

Shen Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY
    Publication number: 20240110179
    Abstract: CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.
    Type: Application
    Filed: November 28, 2022
    Publication date: April 4, 2024
    Applicant: EDITAS MEDICINE, INC.
    Inventors: Shen SHEN, Penrose O'DONNELL, Minerva SANCHEZ
  • GOLF TEE
    Publication number: 20240058669
    Abstract: A golf tee has a shaft and a top plate. The top plate is mounted on a top of the shaft. The top plate has an up-facing ball-supporting surface. The shaft inclines toward a direction of stroke and is oblique with respect to the ball-supporting surface, so that the shaft and a center line of the ball-supporting surface include an inclination angle therebetween. The top plate further has a plurality of spaced bulges arranged along a rim of the ball-supporting surface. Thereby, the golf tee helps improve hitting accuracy and carry distance.
    Type: Application
    Filed: August 17, 2023
    Publication date: February 22, 2024
    Inventor: Wei Shen SHEN
  • COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
    Publication number: 20230295725
    Abstract: Compositions and methods for treatment of CEP290 related diseases are disclosed.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 21, 2023
    Applicant: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee MAEDER, Rina J. MEPANI, David A. BUMCROT, Shen SHEN, Michael STEFANIDAKIS
  • COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
    Publication number: 20230038993
    Abstract: Compositions and methods for treatment of CEP290 related diseases are disclosed.
    Type: Application
    Filed: February 2, 2021
    Publication date: February 9, 2023
    Applicant: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee MAEDER, Rina J. MEPANI, David A. BUMCROT, Shen SHEN, Michael STEFANIDAKIS
  • CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER'S CONGENITAL AMAUROSIS 10 (LCA10)
    Publication number: 20230025279
    Abstract: CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.
    Type: Application
    Filed: March 7, 2022
    Publication date: January 26, 2023
    Applicant: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee MAEDER, David A. BUMCROT, Shen SHEN
  • Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
    Patent number: 11512311
    Abstract: CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: November 29, 2022
    Assignee: EDITAS MEDICINE, INC.
    Inventors: Shen Shen, Penrose O'Donnell, Minerva Sanchez
  • COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
    Publication number: 20220273818
    Abstract: Compositions and methods for treatment of CEP290 related diseases are disclosed.
    Type: Application
    Filed: October 11, 2021
    Publication date: September 1, 2022
    Applicant: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee MAEDER, Rina J. MEPANI, David A. BUMCROT, Shen SHEN, Michael STEFANIDAKIS
  • Compositions and methods for treating CEP290-associated disease
    Patent number: 11339437
    Abstract: Compositions and methods for treatment of CEP290 related diseases are disclosed.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: May 24, 2022
    Assignee: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee Maeder, Rina J. Mepani, David A. Bumcrot, Shen Shen, Michael Stefanidakis
  • CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
    Patent number: 11268086
    Abstract: CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: March 8, 2022
    Assignee: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee Maeder, David A. Bumcrot, Shen Shen
  • Compositions and methods for treating CEP290-associated disease
    Patent number: 11141493
    Abstract: Compositions and methods for treatment of CEP290 related diseases are disclosed.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: October 12, 2021
    Assignee: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee Maeder, Rina J. Mepani, David A. Bumcrot, Shen Shen, Michael Stefanidakis
  • Methods and compositions for targeted gene transfer
    Patent number: 10907176
    Abstract: The present invention provides AAV capsid proteins comprising a modification in the amino acid sequence and virus capsids and virus vectors comprising the modified AAV capsid protein. The invention also provides methods of administering the virus vectors and virus capsids of the invention to a cell or to a subject in vivo.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: February 2, 2021
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Aravind Asokan, Giridhar Murlidharan, Shen Shen
  • Apparatus and method of voltage regulation control for integrated circuit
    Patent number: 10866608
    Abstract: One embodiment relates to a method of controlling supply voltage regulation within an integrated circuit. An external interrupt is sent from an external interaction processing layer to a processor in the integrated circuit. Off-die instructions are generated by the external interaction processing layer and sent to the processor. The off-die instructions are executed by the processor to test and adjust supply voltage regulation within the integrated circuit on a sector-by-sector basis. Another embodiment relates to a method of controlling a supply voltage regulator for a sector of an integrated circuit. Commands are sent by a processor and translated by a sector manager to bits. The bits are loaded into registers so as to set the regulator control circuit to the testing mode send a supply voltage to an analog-to-digital converter. Other embodiments and features are also disclosed.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: December 15, 2020
    Assignee: Intel Corporation
    Inventors: Eng Ling Ho, Ping-Chen Liu, Chiew Siang Wong, Siaw Chen Lee, Shen Shen Lee
  • SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY
    Publication number: 20200216843
    Abstract: CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.
    Type: Application
    Filed: March 24, 2017
    Publication date: July 9, 2020
    Inventors: Shen SHEN, Penrose O'DONNELL, Minerva SANCHEZ
  • CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER'S CONGENITAL AMAUROSIS 10 (LCA10)
    Publication number: 20200017849
    Abstract: CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.
    Type: Application
    Filed: February 19, 2019
    Publication date: January 16, 2020
    Inventors: Morgan Lee MAEDER, David A. BUMCROT, Shen SHEN
  • CONTEXTUAL AGGREGATION OF COMMUNICATIONS WITHIN AN APPLICANT TRACKING SYSTEM
    Publication number: 20190325064
    Abstract: The disclosed embodiments provide a system for processing data. During operation, the system obtains, from multiple platforms, a set of communications between recruiters and applicants. Next, the system automatically identifies a recruiting context from one or more attributes of a first communication in the set of communications, wherein the recruiting context includes an applicant associated with an opportunity. The system also stores an association between the recruiting context and the first communication. The system then aggregates the first communication with additional communications associated with the recruiting context. Finally, the system displays the aggregated communications within a user interface that is separate from a platform used to transmit the first communication.
    Type: Application
    Filed: April 24, 2018
    Publication date: October 24, 2019
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Christian V. Mathiesen, Wai Lim W. Pong, Shen Shen
  • COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
    Publication number: 20190201550
    Abstract: Compositions and methods for treatment of CEP290 related diseases are disclosed.
    Type: Application
    Filed: August 2, 2018
    Publication date: July 4, 2019
    Inventors: Morgan Lee MAEDER, Rina J. MEPANI, David A. BUMCROT, Shen SHEN, Michael STEFANIDAKIS
  • CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
    Patent number: 10253312
    Abstract: CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: April 9, 2019
    Assignee: EDITAS MEDICINE, INC.
    Inventors: Morgan Lee Maeder, David A. Bumcrot, Shen Shen
  • CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER'S CONGENITAL AMAUROSIS 10 (LCA10)
    Publication number: 20180195058
    Abstract: CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 12, 2018
    Inventors: Morgan Lee MAEDER, David A. BUMCROT, Shen SHEN
  • COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
    Publication number: 20180155789
    Abstract: Compositions and methods for treatment of CEP290 related diseases are disclosed.
    Type: Application
    Filed: August 2, 2017
    Publication date: June 7, 2018
    Inventors: Morgan Lee MAEDER, Rina J. MEPANI, David A. BUMCROT, Shen SHEN, Michael STEFANIDAKIS
  • APPARATUS AND METHOD OF VOLTAGE REGULATION CONTROL FOR INTEGRATED CIRCUIT
    Publication number: 20180150095
    Abstract: One embodiment relates to a method of controlling supply voltage regulation within an integrated circuit. An external interrupt is sent from an external interaction processing layer to a processor in the integrated circuit. Off-die instructions are generated by the external interaction processing layer and sent to the processor. The off-die instructions are executed by the processor to test and adjust supply voltage regulation within the integrated circuit on a sector-by-sector basis. Another embodiment relates to a method of controlling a supply voltage regulator for a sector of an integrated circuit. Commands are sent by a processor and translated by a sector manager to bits. The bits are loaded into registers so as to set the regulator control circuit to the testing mode send a supply voltage to an analog-to-digital converter. Other embodiments and features are also disclosed.
    Type: Application
    Filed: November 30, 2016
    Publication date: May 31, 2018
    Applicant: INTEL CORPORATION
    Inventors: Eng Ling HO, Ping-Chen LIU, Chiew Siang WONG, Siaw Chen LEE, Shen Shen LEE